These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 21654152

  • 1. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
    Sagnak L, Ersoy H, Gucuk O, Ozok U, Topaloglu H.
    Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
    [Abstract] [Full Text] [Related]

  • 2. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Smrkolj T, Mihelič M, Sedlar A, Sterle I, Osredkar J, Sedmak B.
    Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Novel NMP22 quick qualitative analysis (BladderChek NMP22) for the diagnosis of urothelial tumor].
    Minagawa T, Nishizawa S, Kamigaito T, Okaneya T.
    Nihon Hinyokika Gakkai Zasshi; 2006 Jan; 97(1):20-6. PubMed ID: 16485550
    [Abstract] [Full Text] [Related]

  • 5. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A, Kumar R, Gupta NP.
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Urinary NMP22 as a new marker in patients with transitional cell carcinoma].
    Muzzonigro G, Minardi D, Galosi AB, Recchioni A, De Sio G, Polito M.
    Arch Ital Urol Androl; 1999 Jun; 71(3):171-7. PubMed ID: 10431409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group].
    Akaza H, Miyanaga N, Tsukamoto T, Ishikawa S, Noguchi R, Ohtani M, Kawabe K, Kubota Y, Fujita K, Obata K, Hirao Y, Kotake T, Ohmori H, Kumazawa J, Koiso K.
    Gan To Kagaku Ryoho; 1997 May; 24(7):837-42. PubMed ID: 9170522
    [Abstract] [Full Text] [Related]

  • 10. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
    Zippe C, Pandrangi L, Potts JM, Kursh E, Novick A, Agarwal A.
    Anticancer Res; 1999 May; 19(4A):2621-3. PubMed ID: 10470205
    [Abstract] [Full Text] [Related]

  • 11. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
    Lotan Y, Shariat SF, NMP22 Study Group.
    BJU Int; 2008 Jun; 101(11):1362-7. PubMed ID: 18284410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Routine urine cytology has no role in hematuria investigations.
    Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B.
    J Urol; 2013 Apr; 189(4):1255-8. PubMed ID: 23079371
    [Abstract] [Full Text] [Related]

  • 15. Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation.
    Terrell JD, Elias KJ, Sagalowsky AI, Lotan Y.
    Int Braz J Urol; 2011 Apr; 37(6):706-11. PubMed ID: 22234001
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Guideline of guidelines: asymptomatic microscopic haematuria.
    Linder BJ, Bass EJ, Mostafid H, Boorjian SA.
    BJU Int; 2018 Feb; 121(2):176-183. PubMed ID: 28921833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.